MALIGNANT MUSCLE NEOPLASM

This adverse event was reported 14 times

These drugs are most commonly taken by patients reporting MALIGNANT MUSCLE NEOPLASM:

# Drug Count
0 ADALIMUMAB 2
1 VEDOLIZUMAB 2
2 ALECTINIB HYDROCHLORIDE 1
3 ALENDRONATE SODIUM 1
4 ALENDRONATE SODIUM TABLET 1
5 AMPHOTERICIN B 1
6 FLUCONAZOLE 1
7 FOLIC ACID 1
8 GILTERITINIB 1
9 HUMAN INSULIN 1
See all common drugs associated with MALIGNANT MUSCLE NEOPLASM

MALIGNANT MUSCLE NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GILTERITINIB 1 0.0002
1 HUMAN INSULIN 1 0.0001
2 ALECTINIB HYDROCHLORIDE 1 0.0001
3 LORLATINIB 1 0.0001
4 AMPHOTERICIN B 1 0.0001
5 PIPERACILLIN AND TAZOBACTAM 1 0.0001
6 OXCARBAZEPINE 1 0.0001
7 ALENDRONATE SODIUM TABLET 1 0.0001
8 VALGANCICLOVIR 1 0.0001
9 PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM 1 0.0001
See all drugs enriched for association with MALIGNANT MUSCLE NEOPLASM

MALIGNANT MUSCLE NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid-based Polyene Antifungal [EPC] 1 0.0001
1 Penem Antibacterial [EPC] 1 0.0000
2 Polyene Antifungal [EPC] 1 0.0000
3 Integrin Receptor Antagonist [EPC] 2 0.0000
4 Insulin [EPC] 1 0.0000
5 Aminosalicylate [EPC] 1 0.0000
6 Azole Antifungal [EPC] 1 0.0000
7 Janus Kinase Inhibitor [EPC] 1 0.0000
8 Interferon beta [EPC] 1 0.0000
9 Anti-epileptic Agent [EPC] 1 0.0000
See all drug classes enriched for association with MALIGNANT MUSCLE NEOPLASM